IL36B and inflammatory bowel disease: Nevertheless, based on the observation from Nishida et al. and ourselves, we speculate that, to contribute to pathogenesis, the production of IL-36β may require substantial alteration, i.e. a moderate to minor change in IL-36β in IBD, but a substantial change in CRC.